These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35380005)
1. Safety and Efficacy of Nafcillin for Empiric Therapy of Late-Onset Sepsis in the NICU. Magers J; Prusakov P; Speaks S; Conroy S; Sánchez PJ Pediatrics; 2022 May; 149(5):. PubMed ID: 35380005 [TBL] [Abstract][Full Text] [Related]
2. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Rubin LG; Sánchez PJ; Siegel J; Levine G; Saiman L; Jarvis WR; Pediatrics; 2002 Oct; 110(4):e42. PubMed ID: 12359815 [TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois. Mongkolrattanothai K; Aldag JC; Mankin P; Gray BM BMC Infect Dis; 2009 Jul; 9():112. PubMed ID: 19607683 [TBL] [Abstract][Full Text] [Related]
5. Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009. Dolapo O; Dhanireddy R; Talati AJ BMC Pediatr; 2014 May; 14():121. PubMed ID: 24886471 [TBL] [Abstract][Full Text] [Related]
6. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia. McConeghy KW; Bleasdale SC; Rodvold KA Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343 [TBL] [Abstract][Full Text] [Related]
7. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. Lawrence SL; Roth V; Slinger R; Toye B; Gaboury I; Lemyre B BMC Pediatr; 2005 Dec; 5():49. PubMed ID: 16375769 [TBL] [Abstract][Full Text] [Related]
8. Empirical antimicrobial therapy for late-onset sepsis in a neonatal unit with high prevalence of coagulase-negative Staphylococcus. Romanelli RM; Anchieta LM; Bueno E Silva AC; de Jesus LA; Rosado V; Clemente WT J Pediatr (Rio J); 2016; 92(5):472-8. PubMed ID: 27112033 [TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates. Rasigade JP; Raulin O; Picaud JC; Tellini C; Bes M; Grando J; Ben Saïd M; Claris O; Etienne J; Tigaud S; Laurent F PLoS One; 2012; 7(2):e31548. PubMed ID: 22348102 [TBL] [Abstract][Full Text] [Related]
10. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Chambers HF; Sande MA Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747 [TBL] [Abstract][Full Text] [Related]
11. [Management of late-onset sepsis due to coagulase-negative staphylococci in neonatal intensive care units]. Rasigade JP; Bensaid M; Butin M; Picaud JC; Laurent F Arch Pediatr; 2013 Sep; 20(9):1028-33. PubMed ID: 23896085 [TBL] [Abstract][Full Text] [Related]
12. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy. Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG Neonatology; 2011; 100(2):180-5. PubMed ID: 21455008 [TBL] [Abstract][Full Text] [Related]
13. Staphylococcus capitis and NRCS-A clone: the story of an unrecognized pathogen in neonatal intensive care units. Laurent F; Butin M Clin Microbiol Infect; 2019 Sep; 25(9):1081-1085. PubMed ID: 30928561 [TBL] [Abstract][Full Text] [Related]
14. Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia. Alvarez CA; Giuliano CA; Haase KK; Thompson KA; Frei CR; Forcade NA; Brouse SD; Mortensen EM; Bell T; Bedimo RJ; Toups NM; Hall RG Am J Med Sci; 2014 Nov; 348(5):371-6. PubMed ID: 24762747 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Krediet TG; Jones ME; Gerards LJ; Fleer A Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
18. Sepsis treatment options identified by 10-year study of microbial isolates and antibiotic susceptibility in a level-four neonatal intensive care unit. Størdal EH; Solevåg AL; Bjørnholt JV; Rønnestad A; Stensvold HJ Acta Paediatr; 2022 Mar; 111(3):519-526. PubMed ID: 34787905 [TBL] [Abstract][Full Text] [Related]
19. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS; Trials; 2016 Mar; 17():170. PubMed ID: 27029920 [TBL] [Abstract][Full Text] [Related]
20. Utility of surveillance cultures for antimicrobial resistant organisms in infants transferred to the neonatal intensive care unit. Macnow T; O'Toole D; DeLaMora P; Murray M; Rivera K; Whittier S; Ross B; Jenkins S; Saiman L; Duchon J Pediatr Infect Dis J; 2013 Dec; 32(12):e443-50. PubMed ID: 23811747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]